JP2014516033A5 - - Google Patents

Download PDF

Info

Publication number
JP2014516033A5
JP2014516033A5 JP2014511450A JP2014511450A JP2014516033A5 JP 2014516033 A5 JP2014516033 A5 JP 2014516033A5 JP 2014511450 A JP2014511450 A JP 2014511450A JP 2014511450 A JP2014511450 A JP 2014511450A JP 2014516033 A5 JP2014516033 A5 JP 2014516033A5
Authority
JP
Japan
Prior art keywords
halo
independently hydrogen
independently
medicament according
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014511450A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014516033A (ja
JP5833745B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/037895 external-priority patent/WO2012158672A2/en
Publication of JP2014516033A publication Critical patent/JP2014516033A/ja
Publication of JP2014516033A5 publication Critical patent/JP2014516033A5/ja
Application granted granted Critical
Publication of JP5833745B2 publication Critical patent/JP5833745B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014511450A 2011-05-16 2012-05-15 粘膜炎の治療に使用するための化合物 Expired - Fee Related JP5833745B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161486455P 2011-05-16 2011-05-16
US61/486,455 2011-05-16
PCT/US2012/037895 WO2012158672A2 (en) 2011-05-16 2012-05-15 Compounds for use in treatment of mucositis

Publications (3)

Publication Number Publication Date
JP2014516033A JP2014516033A (ja) 2014-07-07
JP2014516033A5 true JP2014516033A5 (enExample) 2015-07-02
JP5833745B2 JP5833745B2 (ja) 2015-12-16

Family

ID=47175383

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014511450A Expired - Fee Related JP5833745B2 (ja) 2011-05-16 2012-05-15 粘膜炎の治療に使用するための化合物

Country Status (14)

Country Link
US (6) US8802683B2 (enExample)
EP (1) EP2709619B1 (enExample)
JP (1) JP5833745B2 (enExample)
KR (1) KR102012164B1 (enExample)
CN (1) CN103957710B (enExample)
AU (1) AU2012255935B2 (enExample)
CA (1) CA2836099C (enExample)
DK (1) DK2709619T3 (enExample)
IL (1) IL229381B (enExample)
MX (1) MX2013013330A (enExample)
RU (1) RU2606128C2 (enExample)
TW (1) TWI520951B (enExample)
WO (1) WO2012158672A2 (enExample)
ZA (1) ZA201308541B (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090092574A1 (en) 2006-12-29 2009-04-09 Scott Richard W Ophthalmic And Otic Compositions Of Facially Amphiphilic Polymers And Oligomers And Uses Thereof
RU2606128C2 (ru) 2011-05-16 2017-01-10 Селлсьютикс Корпорейшн Соединения для применения в лечении мукозита
CN104981249B (zh) * 2012-12-18 2018-06-19 英国卫生部 抗微生物化合物、它们的合成及其应用
JP6474736B2 (ja) * 2013-02-15 2019-02-27 テヒーニィシエ ウニヴェルジテート ベルリン アルビシジン誘導体、その使用および合成
BR112015022224A2 (pt) 2013-03-15 2017-07-18 Genzyme Corp poliamidas de amina funcional
JP6047203B2 (ja) * 2015-02-20 2016-12-21 セルセウティックス コーポレイション 消化管の炎症性疾患の予防および/または治療のための宿主防御タンパク質(hdp)模倣薬
JOP20190024A1 (ar) 2016-08-26 2019-02-19 Gilead Sciences Inc مركبات بيروليزين بها استبدال واستخداماتها
KR102526964B1 (ko) 2018-02-26 2023-04-28 길리애드 사이언시즈, 인코포레이티드 Hbv 복제 억제제로서의 치환된 피롤리진 화합물
US11771694B2 (en) 2020-06-05 2023-10-03 Innovation Pharmaceuticals Inc. Arylamide compounds for treatment and prevention of viral infections
JP2024532086A (ja) 2021-08-30 2024-09-05 ユニケム ラボラトリーズ リミテッド 炎症性疾患の処置のためのタンパク質組成物
CN114890982A (zh) * 2022-05-16 2022-08-12 内蒙古大学 一种季铵盐修饰的二苯并噻吩亚砜衍生物的制备方法
CN117402075B (zh) * 2023-10-17 2026-01-09 厦门大学深圳研究院 一种具有特异性抗肿瘤活性的可见光响应的人工h+/ci-离子通道的制备

Family Cites Families (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3496179A (en) 1967-10-11 1970-02-17 Pfizer & Co C 2-amino-3,4-dihydroquinazolines
US5656591A (en) 1992-01-23 1997-08-12 Morinaga Milk Industry Co., Ltd. Antimicrobial agents and method for treating products therewith
US6025326A (en) * 1995-07-07 2000-02-15 Intrabiotics Pharmaceuticals, Inc. Compositions and methods for the prevention and treatment of oral mucositis
US5994306A (en) * 1995-11-22 1999-11-30 Intrabiotics Pharmaceuticals, Inc. Fine-tuned protegrins
JP3090125B2 (ja) 1997-08-26 2000-09-18 千寿製薬株式会社 ソフトコンタクトレンズ用の眼科用組成物、ソフトコンタクトレンズの濡れ増強方法およびテルペノイドの吸着抑制方法
CA2340912C (en) 1998-08-20 2008-11-18 University Of North Carolina At Chapel Hill Dicationic dibenzofuran and dibenzothiophene compounds and methods of use thereof
US20040152664A1 (en) 1998-09-02 2004-08-05 Allergan, Inc. Prednisolone compositions
US6440964B1 (en) 1998-09-30 2002-08-27 Alcon Manufacturing, Ltd. Compositions and methods for treating ophthalmic and otic infections
US6482799B1 (en) 1999-05-25 2002-11-19 The Regents Of The University Of California Self-preserving multipurpose ophthalmic solutions incorporating a polypeptide antimicrobial
JP2001261674A (ja) 2000-03-22 2001-09-26 Mitsui Chemicals Inc ベンゾチオフェン誘導体およびそれを有効成分として含有する核内レセプター作動薬
FR2813080B1 (fr) 2000-08-17 2002-11-29 Stago Diagnostica Peptides anti-heparine
DE60135572D1 (de) 2000-11-08 2008-10-09 Fxs Ventures Llc Verbesserte ophthalmologische und kontaktlinsenlösungen mit einer peroxidquelle und einem kationischen polymeren konservierungsmittel
NZ526821A (en) * 2001-01-18 2005-02-25 Genzyme Corp Ionene polymers and their use as antimicrobial agents
EP2289524A1 (en) 2001-03-08 2011-03-02 The Trustees Of The University Of Pennsylvania Facially amphiphillic polymers as anti-infective agents
US7629317B2 (en) 2001-03-29 2009-12-08 The University Of Chicago Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors
AR034372A1 (es) 2001-06-08 2004-02-18 Novartis Ag Composiciones farmaceuticas
AU2002341566A1 (en) * 2001-08-16 2003-04-01 Mucosal Therapeutics, Inc. Treatment and prevention of mucositis in cancer patients
JP2005529158A (ja) 2002-05-28 2005-09-29 ザ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・ペンシルベニア 両親媒性ポリマーのコンピュータ分析および設計のための方法、システムおよびコンピュータプログラム製品
AU2003239212A1 (en) 2002-06-13 2003-12-31 The Trustees Of The University Of Pennsylvania Methods, systems, and computer program products for simulating biomembranes using coarse grain models
WO2004046109A2 (en) * 2002-11-19 2004-06-03 Genzyme Corporation Ionene oligomers and polymers
CA2519023C (en) * 2003-03-17 2014-05-20 The Trustees Of The University Of Pennsylvania Facially amphiphilic polymers and oligomers and uses thereof
WO2004082643A2 (fr) 2003-03-20 2004-09-30 Shiseido International France Composition cosmetique
US20040202687A1 (en) 2003-04-14 2004-10-14 Babu M.K. Manoj Ciprofloxacin formulations and methods of making and using the same
US20050059639A1 (en) 2003-09-11 2005-03-17 Wei Edward T. Ophthalmic compositions and method for treating eye discomfort and pain
US20050065091A1 (en) 2003-09-18 2005-03-24 Gholam Peyman Stabilized ocular solutions
TWI388280B (zh) 2004-01-23 2013-03-11 Univ Pennsylvania 面上兩性之聚芳基和聚芳炔基聚合物與寡聚物及其用途
EP2380872B1 (en) 2004-06-15 2014-04-23 Cellceutix Corporation Polycationic compounds and uses thereof
WO2006132647A2 (en) 2004-07-23 2006-12-14 The Trustees Of The University Of Pennsylvania Antimicrobial copolymers and uses thereof
EP2301349A2 (en) 2005-02-25 2011-03-30 The Trustees of The University of Pennsylvania Facially amphiphilic polymers and oligomers, compositions thereof, and use thereof in methods of treating cancer
EP1704860B1 (en) * 2005-03-24 2010-10-27 Rottapharm S.P.A. Benzamidine derivatives for treatment and prevention of mucositis
WO2006122162A2 (en) * 2005-05-10 2006-11-16 The University Of Chicago Use of peptides derived from the growth factor amp-18 for the treatment of mucositis
US7951829B2 (en) * 2006-05-03 2011-05-31 Janssen Pharmaceutica Nv Benzimidazole modulators of VR1
JP2008137978A (ja) 2006-12-05 2008-06-19 Canon Inc カルバゾール誘導体及びこれを用いた有機発光素子
US20090092574A1 (en) * 2006-12-29 2009-04-09 Scott Richard W Ophthalmic And Otic Compositions Of Facially Amphiphilic Polymers And Oligomers And Uses Thereof
US20100297257A1 (en) 2007-11-09 2010-11-25 National Institutes Of Health (Nih), U.S. Dept. Of Health And Human Services (Dhhs) Anticoagulant antagonist and hemophillia procoagulant
MX2011000971A (es) 2008-07-28 2011-06-24 Polymedix Inc Compuestos antipaludicos.
TWI478915B (zh) * 2008-10-27 2015-04-01 Cellceutix Corp 宿主防禦之合成模擬物及其用途
RU2011128373A (ru) * 2008-12-10 2013-01-20 Полимедикс, Инк. Молекулы с антимикробной активностью в отношении штаммов микобактерий с множественной лекарственной устойчивостью и широкой лекарственной устойчивостью
UA110323C2 (en) * 2009-06-04 2015-12-25 Promedior Inc Derivative of serum amyloid p and their receipt and application
WO2011084970A1 (en) * 2010-01-07 2011-07-14 Polymedix Inc. Anti-heparin compounds
TW201208677A (en) * 2010-08-21 2012-03-01 Polymedix Inc Facially amphiphilic compounds, compositions, and uses thereof in treating cancer
RU2606128C2 (ru) * 2011-05-16 2017-01-10 Селлсьютикс Корпорейшн Соединения для применения в лечении мукозита
AU2012352621A1 (en) * 2011-12-13 2014-07-24 Cellceutix Corporation Cyclic compounds and methods of making and using the same
BR112014017642A2 (pt) * 2012-01-18 2019-09-24 Cellceutix Corp método para exterminar ou inibir o desenvolvimento de uma espécie de candida ou aspergillus ou prevenir ou tratar o mamífero apresentando candidíase oral ou disseminada ou uma infecção por aspergillus, composto, e, uso de um composto
US20140171438A1 (en) * 2012-12-10 2014-06-19 Cellceutix Corporation Hybrid Compounds And Methods Of Making And Using The Same
US20140308317A1 (en) * 2012-12-10 2014-10-16 Cellceutix Corporation Polymeric Compounds And Methods Of Making And Using The Same
CN105246476B (zh) * 2013-05-28 2019-11-15 莫弗凯姆联合化学股份公司 含噁唑烷酮-喹诺酮的联合疗法在治疗细菌感染中的应用
JP6047203B2 (ja) * 2015-02-20 2016-12-21 セルセウティックス コーポレイション 消化管の炎症性疾患の予防および/または治療のための宿主防御タンパク質(hdp)模倣薬

Similar Documents

Publication Publication Date Title
JP2013508279A5 (enExample)
JP2006524660A5 (enExample)
JP2013542247A5 (enExample)
JP2013512277A5 (enExample)
JP2013542261A5 (enExample)
JP2010525056A5 (enExample)
JP2013531031A5 (enExample)
JP2009523760A5 (enExample)
JP2013534248A5 (enExample)
HRP20171648T1 (hr) Supstituirani piperidil-etil-pirimidin kao inhibitor grelin-o-acil-transferaze
JP2013537203A5 (enExample)
JP2014513051A5 (enExample)
JP2013532687A5 (enExample)
JP2016503793A5 (enExample)
JP2013510120A5 (enExample)
JP2015501783A5 (enExample)
JP2016509589A5 (enExample)
RU2015117251A (ru) Новые соединения
HRP20151000T1 (hr) Antivirusni spojevi
JP2007302689A5 (enExample)
JP2014500861A5 (enExample)
JP2009507896A5 (enExample)
JP2012512863A5 (enExample)
JP2012092103A5 (enExample)
JP2011246469A5 (enExample)